12至24月龄健康儿童血磷浓度及其影响因素
本研究纳入525名健康婴儿(53%为女孩),参与维生素D干预随机试验,每日补充10或30μg维生素D3至24月龄。血磷均值从12月龄的1.9±0.15 mmol/L降至24月龄的1.6±0.17 mmol/L(P<0.001)。调整协变量后男孩血磷高于女孩(P=0.019),维生素D干预组间血磷相似(P>0.472),血浆铁与血磷正相关,24月龄时血肌酐是主要影响因素。
要点
- 健康婴幼儿血磷从12月龄至24月龄显著下降。
- 维生素D补充剂量(10或30μg/日)不影响血磷浓度。
- 男孩血磷高于女孩,血浆铁和肌酐是重要影响因素。
核心结论
- 12至24月龄健康婴幼儿血浆磷酸盐浓度随年龄增长而下降。
- 性别、血浆铁和肌酐是血磷浓度的最强影响因素,维生素D补充不改变血磷。
研究设计与样本
- 研究纳入525名健康婴儿(53%为女孩),来自一项随机维生素D干预试验。
- 婴儿从2周龄至24月龄每日补充10或30μg维生素D3,在12和24月龄检测生化指标,12月龄评估膳食磷摄入。
主要发现
- 血磷均值(标准差)从12月龄的1.9±0.15 mmol/L降至24月龄的1.6±0.17 mmol/L(重复测量P<0.001)。
- 调整体型、肌酐、血清25-羟维生素D、完整及C端成纤维细胞生长因子23等协变量后,男孩血磷高于女孩(P=0.019)。
- 两个维生素D干预组血磷浓度相似(所有P>0.472)。
- 血浆铁与血磷在12和24月龄均呈正相关(B=0.006和0.005;95%CI 0.004-0.009和0.002-0.008;均P<0.001)。
- 24月龄时血磷的主要影响因素是血浆肌酐(B=0.007;95%CI 0.003-0.011;P<0.001)。
临床怎么用
- 解读婴幼儿血磷时应考虑年龄、性别、血浆铁和肌酐水平。
- 维生素D补充剂量(10或30μg/日)不显著影响血磷,无需据此调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Phosphate homeostasis and its modifiers in early childhood are inadequately characterized. OBJECTIVE: To determine physiological plasma phosphate concentration and modifying factors in healthy infants at 12 to 24 months of age. DESIGN: This study included 525 healthy infants (53% girls), who participated in a randomized vitamin D intervention trial and received daily vitamin D3 supplementation of either 10 or 30 μg from age 2 weeks to 24 months. Biochemical parameters were measured at 12 and 24 months. Dietary phosphate intake was determined at 12 months. MAIN OUTCOME MEASURES: Plasma phosphate concentrations at 12 and 24 months of age. RESULTS: Mean (SD) phosphate concentration decreased from 12 months (1.9 ± 0.15 mmol/L) to 24 months (1.6 ± 0.17 mmol/L) of age (P < 0.001 for repeated measurements). When adjusted by covariates, such as body size, creatinine, serum 25-hydroxyvitamin D, intact and C-terminal fibroblast growth factor 23, mean plasma phosphate was higher in boys than girls during follow-up (P = 0.019). Phosphate concentrations were similar in the vitamin D intervention groups (P > 0.472 for all). Plasma iron was associated positively with plasma phosphate at both time points (B, 0.006 and 0.005; 95% CI, 0.004-0.009 and 0.002-0.008; P < 0.001 at both time points, respectively). At 24 months of age, the main modifier of phosphate concentration was plasma creatinine (B, 0.007; 95% CI 0.003-0.011, P < 0.001). CONCLUSION: Plasma phosphate concentration decreased from age 12 to 24 months. In infants and toddlers, the strongest plasma phosphate modifiers were sex, iron, and creatinine, whereas vitamin D supplementation did not modify phosphate concentrations.
引用
- Koljonen L, Enlund-Cerullo M, Hauta-Alus H, et al. Phosphate Concentrations and Modifying Factors in Healthy Children From 12 to 24 Months of Age. J Clin Endocrinol Metab. 2021. PMID: 34214153. doi:10.1210/clinem/dgab495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。